SynapCell is Discovery Tools (Healthcare) in France that focus on disease-modifying assays business. Founded in 2005. They cover business area such as developer, CNS, ) disorder, dose-response study, pharmacodynamic, biomarker identification, modulation, disease-modify assay, model phenotyping, phenotypic screening, lead selection, validation, decision-make asset, their preclinical drug discovery program.
2005
( 19 years old in 2024 )
Disease-modifying Assays
-
Bâtiment Synergy
ZAC isiparc
38330 Saint Ismier
France
Private
developerCNS) disorderdose-response studypharmacodynamicbiomarker identificationmodulationdisease-modify assaymodel phenotypingphenotypic screeninglead selectionvalidationdecision-make assettheir preclinical drug discovery program
* We use standard office opening hours in near SynapCell's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
SynapCell is Discovery Tools (Healthcare) business from France that founded in 2005 (19 years old in 2024), SynapCell business is focusing on Disease-modifying Assays.
SynapCell headquarter office and corporate office address is located in Bâtiment Synergy ZAC isiparc 38330 Saint Ismier France.
SynapCell was founded in France.
In 2024, SynapCell is currently focus on disease-modifying assays sector.
Above is snippet of Google Trends for "disease-modifying assays" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with SynapCell, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
